KRAS and colorectal carcinoma: Downregulated NEAT1 impaired the viability of CRC cells whereas miR-193a-3p inhibition increased tumor cell proliferation and migration, and reduced CRC apoptosis by targeting Kirsten rat sarcoma viral oncogene homology (KRAS) expression [86].